S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

IQVIA Shares Surge as Quarterly Earnings Outpace Market Expectations

Shares of IQVIA Holdings climbed 8.3% to $230.99 in premarket trading after the biopharmaceutical services provider reported second-quarter revenue of $4.37 billion. This performance surpassed analyst projections of $4.3 billion, signaling a robust recovery for the company as it approaches its 52-week price high.

IQVIA Shares Surge as Quarterly Earnings Outpace Market Expectations

The company’s adjusted earnings reached $3.15 per share, comfortably beating the $3.03 forecast set by FactSet analysts. This growth is underpinned by a significant expansion in the firm’s contract pipeline, with net new bookings rising 19% compared to the same period last year.

IQVIA concluded the quarter with a record backlog of $34.2 billion. Management anticipates converting approximately $9.2 billion of this total into revenue over the coming twelve months, providing a stable outlook for the research organization's commercial outsourcing operations.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!